Abstract 6693: Metronomic treatment of orally available oxaliplatin and pemetrexed to potentiate the efficacy of anti-PD-1 by modulating tumor immunity
Cancer Res (2020) 80 (16_Supplement): 6693.
Currently there are no citedby results. Try again later.
